Dysregulation of tau splicing, increased expression of longer tau isoforms containing exon 10, and disease-like tau modifications have been shown to be associated with the development of tauopathies indicating a major role of changes in tau expression and post-translational modifications for disease development (9–11). Here, MAPT is linked to tauopathy.